Table 1.
Baseline Patient Characteristics of 91 Patients
| Variable | Value |
|---|---|
| Age, yr | 47±19 (14–83) |
| Male:female | 60 (65.9):31 (34.1) |
| BMI, kg/m2 | 20.9±3.1 |
| Duration of chronic diarrhea, mo | 8.3±14.7 (1–120) |
| Weight loss | 51 (56) |
| Abdominal pain | 63 (69.2) |
| Hematochezia | 14 (15.4) |
| Diabetes mellitus | 5 (5.5) |
| Thyroid disorder | 0 |
| Drug history | |
| NSAIDs | 2 (2.2) |
| Aspirin | 3 (3.3) |
| Anticoagulant | 1 (1.1) |
| Steroid | 2 (2.2) |
| Prior VCE exam | |
| Upper endoscopy | 68 (74.7) |
| Colonoscopy | 74 (81.3) |
| Abdominopelvic CT | 52 (57.1) |
| Small bowel series | 18 (19.8) |
| Double balloon enteroscopy | 2 (2.2) |
| Anemia* | 37 (40.7) |
| WBC >10,000/mm3 | 4 (4.4) |
| ESR >20 mm/hr | 22 (24.2) |
| CRP ≥0.4 mg/dL | 26 (28.6) |
| Positive inflammatory markers | 28 (30.8) |
| Albumin <3.0 g/dL | 15 (16.5) |
Data are presented as mean±SD (range) or number (%).
BMI, body mass index; NSAIDs, nonsteroidal anti-inflammatory drugs; VCE, video capsule endoscopy; CT, computed tomography; WBC, white blood cell; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
*
Male, hemoglobin <13.0 g/dL; female, hemoglobin <12.0 g/dL.